UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012871
Receipt number R000015029
Scientific Title Poor-Risk patients wIth and withOut RevascularIzation TherapY for critical limb ischemia
Date of disclosure of the study information 2014/01/20
Last modified on 2018/07/23 14:28:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Poor-Risk patients wIth and withOut RevascularIzation TherapY for critical limb ischemia

Acronym

PRIORITY Registry

Scientific Title

Poor-Risk patients wIth and withOut RevascularIzation TherapY for critical limb ischemia

Scientific Title:Acronym

PRIORITY Registry

Region

Japan


Condition

Condition

Critical Limb Ischemia

Classification by specialty

Cardiology Vascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Effectiveness of endovascular and surgical revascularization for CLI patients with impaired activities of daily living or dementia

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

12-months survival rate after registration

Key secondary outcomes

a. cause-specific death rate
b. major amputation rate
c. amputation-free survival rate
d. presence or absence of rest pain after revascularization, ADL, QOL, total number of revascularization


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

a. Patients and their families who can provide an informed consent and patients are aged 20 years or older when providing the consent.
b. CLI has been diagnosed in one or both limbs.
c. Patients who need assistance in daily living because of impaired ADL or dementia.

Key exclusion criteria

patient may not complete follow up at 12 follow up

Target sample size

250


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Osamu Iida

Organization

Kansai Rosai Hospital

Division name

Cardiovascular Center

Zip code


Address

3-1-69 Inabaso, Amagasaki-shi, Hyogo

TEL

06-6416-1221

Email

iida.osa@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Osamu Iida

Organization

Kansai Rosai Hospital

Division name

Cardiovascular Center

Zip code


Address

3-1-69 Inabaso, Amagasaki-shi, Hyogo

TEL

06-6416-1221

Homepage URL


Email

iida.osa@gmail.com


Sponsor or person

Institute

PRIORITY Registry Study Group

Institute

Department

Personal name



Funding Source

Organization

PRIORITY Registry Study Group

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 01 Month 20 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Iida O, et al. Prognostic Impact of Revascularization in Poor-Risk Patients With Critical Limb Ischemia: The PRIORITY Registry (Poor-Risk Patients With and Without Revascularization Therapy for Critical Limb Ischemia). JACC Cardiovasc Interv. 10: 1147-1157, 2017.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 01 Month 09 Day

Date of IRB


Anticipated trial start date

2014 Year 02 Month 17 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2014 Year 01 Month 16 Day

Last modified on

2018 Year 07 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015029


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name